Biorez, Inc., a New Haven, Conn.-based medical device company advancing tendon and ligament repair, raised $3.5m in seed financing, adding to $3.5m raised previously.
The round was led by New York Angels, with participation from Connecticut Innovations, Pritzker Vlock Family Office, Brainchild Holdings, and The Vertical Group.
Led by Kevin Rocco, President and CEO, Biorez has developed the BioBrace™ implant, a material featuring a porous collagen sponge reinforced with bioresorbable microfilaments. The BioBrace implant is intended to augment and reinforce a wide range of tendon and ligament procedures, including rotator cuff repair and ACL reconstruction.
The products are in the development stage and have not been approved for use by any regulatory agency including the US Food and Drug Administration.
FinSMEs
14/09/2020